Form 8-K - Current report:
SEC Accession No. 0000950170-24-138772
Filing Date
2024-12-20
Accepted
2024-12-20 07:07:05
Documents
15
Period of Report
2024-12-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aplt-20241219.htm   iXBRL 8-K 65716
2 EX-10.1 aplt-ex10_1.htm EX-10.1 89014
3 EX-10.2 aplt-ex10_2.htm EX-10.2 41013
4 EX-10.3 aplt-ex10_3.htm EX-10.3 84324
5 GRAPHIC img142114255_0.jpg GRAPHIC 6185
  Complete submission text file 0000950170-24-138772.txt   457245

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aplt-20241219.xsd EX-101.SCH 27529
17 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20241219_htm.xml XML 5041
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filer) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38898 | Film No.: 241565092
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)